HILLIARD, Ohio (WCMH) — A proposal to fuel an Amazon data center in Hilliard is facing formal opposition from local leaders despite the project’s assertion it does not need their permission to move ...

For the hundreds of communities who’ve been saddled with data centers in recent years, the bulky fixtures are sources of unbearable noise, soaring energy prices, and plenty of electrical fires. Add ...

The IEA's report highlights a widening gap between what governments promise on renewables vs. what they are actually building. Nowhere is this divergence clearer than in the U.S., where "world-leading ...

Mark Tsagas does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Everyone’s heard the old line about death and taxes being eternal, but these days, we can certainly add data breaches to the list. Hyundai was recently at the center of another one, as its IT services ...

Have you ever opened an Excel spreadsheet and felt instantly overwhelmed by its endless rows, columns, and cryptic formulas? You’re not alone. Many people see Excel as a labyrinth of complexity, ...

One of the most important rules of cell phone use? Don’t go over your data limit. Overages can lead to a more expensive bill than you’d been planning for. Indeed, anyone who has a cell phone-armed ...

Saturn’s moon Titan may be more alive with possibilities than we thought. New NASA research suggests that in Titan’s freezing methane and ethane lakes, simple molecules could naturally arrange ...

The native token of the Chainlink network, LINK, surged more than 5% after the network announced a partnership with the U.S. Department of Commerce to bring official government economic data onchain, ...

The new ‘COPILOT’ function uses AI to generate summaries, tags, tables, and more based on a group of cells. The new ‘COPILOT’ function uses AI to generate summaries, tags, tables, and more based on a ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing back from ...